(4-Bromophenyl)[2-fluoro-4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]methanone

CAS : 161582-11-2

Ref. 3D-FB100752

Informations sur le produit

• Nom: (4-Bromophenyl)[2-fluoro-4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]methanone
• Synonymes: (4-Bromophenyl)-[2-fluoro-4-[6-[methyl(prop-2-enyl)amino]hexoxy]phenyl]methanone, (4-Bromophenyl)[2-Fluoro-4-({6-[Methyl(Prop-2-En-1-Yl)Amino]Hexyl}Oxy)Phenyl]Methanone, (4-Bromophenyl)[2-fluoro-4-[[6-(methyl-2-propen-1-ylamino)hexyl]oxy]phenyl]methanone, Methanone, (4-bromophenyl)[2-fluoro-4-[[6-(methyl-2-propen-1-ylamino)hexyl]oxy]phenyl]-, Methanone, (4-bromophenyl)[2-fluoro-4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]-, Ro 48-8071

Description

4-Bromophenyl[2-fluoro-4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]methanone (BPPM) is a small molecule that binds to ATP binding cassette transporter proteins. BPPM has been shown to inhibit prostate cancer cell growth and induce apoptosis in vitro. It also has an inhibitory effect on the angiogenic process, which may be due to its ability to inhibit cholesterol synthesis. The drug is currently undergoing preclinical studies as a potential anti-cancer compound with inhibitory properties against cancer cells.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 448.37 g/mol
• Formule: C₂₃H₂₇BrFNO₂
• Degré de pureté: Min. 95%